Clinical Trials

15 enrolled

Recurrence, Hematologic Neoplasms

NCT07456189 2026-03-06

The Efficacy and Safety of Stereotactic Radiotherapy Bridging Allogeneic Hematopoietic Stem Cell Transplantation for the Treatment of Hematological Malignance Patients With Extramedullary Infiltrating

20 enrolled

Phase 2 Not yet recruiting

Hematologic Neoplasms

NCT07137481 2026-03-04

Phase II Study of CD5 CAR Engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Aggressive T Cell Hematological Malignancies

70 enrolled

Hematologic Neoplasms

NCT07297160 2026-03-04

CALySSEY

GenitourinaryLymphoidOther hematologic neoplasmPlasma cellSarcoma

88 enrolled

Kidney Neoplasms, Lymphoma, Sarcoma, Hematologic Neoplasms, Neoplasms, Plasma Cell

NCT07441967 2026-03-02

The Safety and Efficacy of the Regimen of Thiotepa + Fludarabine +Granulocyte Colony-Stimulating Factor+ Cytarabine + Busulfan in Single Unrelated Umbilical Cord Blood Transplantation

Phase 2 Not yet recruiting

44 enrolled

Phase 2/3 Not yet recruiting

Hematologic Neoplasms

NCT07440290 2026-02-27

DETERMINE

30 enrolled

CNSEndocrineGastrointestinalGynecologicHead & NeckLymphoidMyeloidOther hematologic neoplasmPlasma cellThoracic

Thyroid Cancer, Papillary, Carcinoma, Non-Small-Cell Lung, Gastrointestinal Neoplasms, Glioma, Histiocytosis, Langerhans-Cell, Laryngeal Neoplasms, Lymphoproliferative Disorders, Multiple Myeloma, Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Ovarian Neoplasms, Colorectal Neoplasms, Hematologic Neoplasms, Erdheim-Chester Disease, Thyroid Carcinoma, Anaplastic

NCT06897137 2026-02-24

Optimizing Health Related Quality of Life Measurement in Adolescent and Young Adult Oncology

3,000 enrolled

Hematologic Neoplasms

NCT07424833 2026-02-20

A Study of APG-3288 in Relapsed/Refractory Blood Cancers

180 enrolled

Lymphoma, Follicular, Waldenstrom Macroglobulinemia, Recurrence, Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone, Hematologic Neoplasms, Lymphoma, Mantle-Cell

NCT07403812 2026-02-11

Assessing DCog Short for Neurotoxicity in CAR-T

40 enrolled

Hematologic Neoplasms, Neurotoxicity Syndromes

NCT07367997 2026-01-26

CARE-RT

100 enrolled

Neoplasms, Hematologic Neoplasms

NCT07362602 2026-01-23

Exploratory Study on in Vivo CAR-T Therapy Targeting CD20 for the Treatment of Hematological Malignancies

47 enrolled

Hematologic Neoplasms

NCT07362732 2026-01-23

Exploratory Study on the Treatment of Recurrent and Refractory Hematological Malignancies With WGb-0302 Injection

20 enrolled

Hematologic Neoplasms

NCT07358195 2026-01-22

Addition of Venetoclax to Combined Hematopoietic Stem Cell and Kidney Transplantation

3 enrolled

Hematologic Neoplasms, Renal Insufficiency, Chronic

NCT04871477 2026-01-14

Adoption of Audio Recording in the Outpatient Supportive Care Center

200 enrolled

Neoplasm Metastasis, Hematologic Neoplasms

NCT07316907 2026-01-05

A Clinical Study of Allogenic CD19-CAR-T in the Treatment of R/R B-Cell Hematologic Malignancies

12 enrolled

Lymphoma, Recurrence, Hematologic Neoplasms

NCT07294300 2025-12-19

A Phase I Trial of QLS2313 Injection in Relapsed/Refractory Hematological Malignancies

124 enrolled

Hematologic Neoplasms

NCT06345027 2025-12-16

CASEY

12 enrolled

Leukemia, Leukemia, B-Cell, Leukemia, T-Cell, Leukemia, Myeloid, Acute, Hematologic Neoplasms

NCT07286539 2025-12-16

PEPOH

BreastGastrointestinalLymphoidOther hematologic neoplasmThoracic

150 enrolled

Breast Neoplasms, Colonic Neoplasms, Lung Neoplasms, Lymphoma, Motor Activity, Neoplasms, Leukemia, Lymphocytic, Chronic, B-Cell, Hematologic Neoplasms

NCT07255521 2025-12-15

PREHAB-HSCT

68 enrolled

Frailty, Hematologic Neoplasms

NCT07277387 2025-12-11

Plasma Host-Microbe Proteomics to Predict Complications in High-risk Febrile Neutropenia

Classical hematologyOther hematologic neoplasm

350 enrolled

Shock, Septic, Sepsis, Hematologic Neoplasms, Febrile Neutropenia

NCT07234630 2025-12-10

NEO-COAG

150 enrolled

Disseminated Intravascular Coagulation, Hematologic Neoplasms

NCT06225050 2025-12-03

HAPLO2022

18 enrolled

Hematologic Neoplasms

NCT07255898 2025-12-01

A Study of BL-M24D1 in Patients With Relapsed or Refractory Multiple Myeloma and Other Hematologic Malignancies

Other hematologic neoplasmPlasma cell

33 enrolled

Multiple Myeloma, Hematologic Neoplasms

NCT07251348 2025-11-26

Progressive Relaxation and Psychoeducation in Patients With Hematological Malignancies

75 enrolled

Hematologic Neoplasms

NCT07018310 2025-11-20

MAHATMAt

166 enrolled

Phase 1/2 Not yet recruiting

Hematologic Neoplasms

NCT07107204 2025-09-17

A Clinical Study of BT02 in Patients With Relapsed or Refractory Hematologic Malignancies

116 enrolled

LymphoidOther hematologic neoplasmPlasma cell

Leukemia, Lymphoma, Multiple Myeloma, Recurrence, Hematologic Neoplasms

NCT07179094 2025-09-17

The Effect of a Protective Oral Care Protocol Using Peppermint Oil Mouthwash

72 enrolled

Anorexia, Nausea, Vomiting, Hematologic Neoplasms

NCT07145359 2025-08-28

Virtual Reality Intervention for Symptom Management in Stem Cell Transplantation

30 enrolled

Neoplasms, Hematologic Neoplasms

NCT07117175 2025-08-12

A Clinical Study to Evaluate the Safety and Efficacy of Anti-human CD 7 CAR-NK Cell Injection in Subjects With Relapsed and Refractory CD7-positive Hematological Malignancy

18 enrolled

Hematologic Neoplasms

NCT07108010 2025-08-06

ABO and Rh Blood Group Frequencies in Acute Leukemia Patients

300 enrolled

Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT06992934 2025-08-03

TARGETALLO

10 enrolled

Hematologic Neoplasms

NCT07047352 2025-07-02

Prospective Study Evaluate the Timing of Empirical Treatment for Carbapenem-resistant Bacterials (CROEAT Study)

91 enrolled

Phase 2 Not yet recruiting

Neutropenia, Hematologic Neoplasms

NCT07043894 2025-06-29

Romiplostim N01 for Chemotherapy-Induced Thrombocytopenia in Pediatric Cancer Patients

50 enrolled

Hematologic Neoplasms

NCT07039474 2025-06-26

The Application of 18F-G1 PET/CT Targeting Granzyme B in the Pan-cancer Immunotherapy

120 enrolled